Search

everythinglearnresearchcommunity

for

Search:↓

Ginseng was more effective than finasteride in treating enlarged prostate in rats.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

The study's methods are flawed, making its conclusions about finasteride and mental health unreliable.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Urinary PSA could be an early marker for enlarged prostate.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Hair loss linked to prostate enlargement; stress and family history important factors.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Gene variation affects prostate issues and hair loss.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Lespedeza cuneata extract may help treat enlarged prostate.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.